Industries
Disrupt drug development & health innovation with microgravity. With Yuri, pharma and health companies use microgravity to obtain better structures, more predictive 3D models, and unique datasets. De-risking novel modalities and creating defensible differentiation in crowded therapeutic areas.
Microgravity redefining drug discovery
Pharma & health need differentiated therapies while R&D stays expensive and risky. Microgravity offers new ways to screen drugs, test toxicity and grow organoids – Yuri makes this accessible as your microgravity CRO and platform partner.
Disrupting drug discovery & health innovations with microgravity
See how microgravity can plug directly into your pipeline. Each use case is designed to answer a concrete R&D question – with clear readouts, timelines, and next steps for scale-up.
Use Case 1
Use Case 2
Use Case 3
Our hardware platforms and CRO services cover the full lifecycle of your in-orbit R&D. Designed for pharma & health companies, these solutions provide automated, standardized incubator capacity for drug screening, toxicity testing and organoid studies in microgravity.